Drugs & Pharmaceutical Industry News

Drugs

Stem-cell Debate Unlikely To Fade After Neb. Vote

Latest U. of Nebraska debate over embryonic stem-cell research shows dispute unlikely to fade

11/20/09 - 06:39 AM EST

Novavax Plans Offering Of 6.8M Shares; Stock Falls

  • Tickers in this article:
  • NVAX

Drug developer Novavax to offer 6.8 million shares of common stock at $3.30 each; stock falls

11/20/09 - 10:36 AM EST

Try Jim Cramer's Action Alerts PLUS
Biotech Stock Mailbag: FDA Playbook

Smart drug and biotech companies keep the FDA abreast of their clinical trial program throughout the long drug-development process.

11/20/09 - 06:01 AM EST

Article

Pfizer to Begin Selling Generics in Japan

  • Tickers in this article:
  • PFE

Pfizer plans to start selling generic drugs in Japan beginning in 2011, a spokesman said, according to reports.

11/19/09 - 12:39 AM EST

Article

U.S. Sees Low Demand for BioCryst Flu Drug

  • Tickers in this article:
  • BCRX
  • GSK

Peaking flu season could mean no need for further peramivir orders.

11/18/09 - 11:12 AM EST

Article

Drugmakers' Differences: Analyst's Toolkit

Pharmaceutical companies require their own metrics of evaluation. Sanofi, which looks strong in some ways, comes across as risky in others.

11/18/09 - 05:00 AM EST

Article

Another Genzyme Drug Goes Kaboom: BioBuzz

Company halts development of kidney disease drug following poor test results.

11/18/09 - 08:05 AM EST

Article

Vivus Seeks Faster ED Drug: Biobuzz

Company says ED drug met all goals in phase III study.

11/18/09 - 06:42 AM EST

Article

Isis Cholesterol Drug Effective, but Safety a Worry: BioBuzz

Mipomersen lowers cholesterol but not without liver side effects.

11/17/09 - 10:56 AM EST

Article

InterMune Hep C Drug Hit With Liver Tox Worry: BioBuzz

Safety monitors force change to mid-stage study of ITMN-191

11/17/09 - 09:11 AM EST

Video

Collagen Disease Breakthrough

NEW YORK (TheStreet) -- Auxilium CEO Armando Anido tells TSC's Debra Borchardt of the future plans for its soon-to-be-launched drug Xiaflex for collagen based diseases.

11/16/09 - 09:00 AM EST

Article

Poniard's CEO Pulls a Belichick: BioBuzz

Risky late-game call puts Poniard in a deep financial hole.

11/16/09 - 11:59 AM EST

Article

A Closer Look at Cardium's Wound-Healing Drug: BioBuzz

Is it the drug or the gel that worked best in a phase II study?

11/16/09 - 10:51 AM EST

Article

Cell Therapeutics Lavishes Free Stock on Execs: BioBuzz

'Retention' bonus awarded to CEO Jim Bianco, his management team and directors.

11/16/09 - 09:23 AM EST

Dow Jones S&P 500 NASDAQ 10-Year Note
10,318.16 1,091.38 2,146.04 33.56
Oil *
77.53
DOWN
14.28
DOWN
3.52
DOWN
10.78
UP
0.07
10 Yr
3.36%
SPDR Gold
112.94
-0.14%
-0.32%
-0.50%
+0.21%
Data delayed 20 minutes

Brokerage Partners

TheStreet Premium Services

All Services